Perrigo (NYSE:PRGO) Shares Down 4.8% – What’s Next?

Shares of Perrigo Company plc (NYSE:PRGO) traded down 4.8% on Thursday . The company traded as low as $10.75 and last traded at $10.63. 839,344 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 3,015,777 shares. The stock had previously closed at $11.17.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Canaccord Genuity Group decreased their price objective on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a report on Friday, February 27th. Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. Weiss Ratings lowered Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. Finally, Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $19.33.

Perrigo Stock Performance

The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45. The firm has a fifty day moving average price of $11.18 and a 200 day moving average price of $12.47. The firm has a market cap of $1.50 billion, a PE ratio of -0.82, a price-to-earnings-growth ratio of 1.33 and a beta of 0.51.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.39 by $0.04. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The business had revenue of $841.80 million for the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the previous year, the firm earned $0.60 EPS. The company’s quarterly revenue was down 7.2% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities research analysts expect that Perrigo Company plc will post 2.11 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Friday, May 29th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 10.7%. The ex-dividend date of this dividend is Friday, May 29th. Perrigo’s dividend payout ratio (DPR) is presently -8.85%.

Hedge Funds Weigh In On Perrigo

Several institutional investors have recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its position in shares of Perrigo by 3.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,574,227 shares of the company’s stock worth $244,634,000 after buying an additional 653,925 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Perrigo by 7.9% during the fourth quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock worth $208,568,000 after buying an additional 1,101,154 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its position in shares of Perrigo by 291.9% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock worth $108,921,000 after buying an additional 5,828,076 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Perrigo by 2.4% during the third quarter. Dimensional Fund Advisors LP now owns 7,695,238 shares of the company’s stock worth $171,367,000 after buying an additional 181,828 shares in the last quarter. Finally, State Street Corp grew its position in shares of Perrigo by 9.5% during the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after buying an additional 637,678 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.